2C-P

The legacy wording is corrected to the canonical restricted_other status and the official lower-case category name Verzeichnis e. The current consolidated BetmVV-EDI expressly names 2C-P and supplies its chemical designation in Annex 6 item 10. BetmVV-EDI Article 1(2)(a) treats Annex 1–6 entries as controlled substances and Article 2(2) places Verzeichnis e in Annex 6. BetmKV Article 3(2)(e) subjects Verzeichnis-e entries to the control measures applicable to Verzeichnis-a narcotics, Article 5(2) assigns the operating permit for handling them to the EDI, and Article 11(1) requires an operating permit for listed handling activities including manufacture, obtaining, brokering, import/export, supply and trade. BetmG Article 7(1) requires EDI authorization and compliance with its conditions for cultivating, manufacturing, importing, exporting, storing, using or placing Article 7 materials/products into circulation; Article 20(1)(c) provides up to three years' imprisonment or a monetary penalty for specified unauthorized conduct involving Article 7 substances/products. These sources support a permit-based restricted_other classification, not an assertion that 2C-P is in Verzeichnis d or that every possible act is categorically prohibited. The exact-name schedule entry does not state a separate 2C-P-specific exemption, so none is asserted.

The legacy note is corrected in precision. Current NPSV § 1(1) Z 2 includes every substance covered by an Anlage II chemical definition, and Anlage II Z 2 covers every compound derivable from a phenethylamine basic structure, including compounds with chemical structures listed in § 1(2) as substituents. PubChem identifies 2C-P as 2-(2,5-dimethoxy-4-propylphenyl)ethanamine, which directly supplies the phenethylamine core and dimethoxy/propyl substitutions. The current SV text and Annex V were inspected: Annex V expressly names several other 2C compounds (2C-B, 2C-I, 2C-T-2 and 2C-T-7) but no 2C-P entry was found; no claim is made that 2C-P is an individually listed Suchtgift. NPSG § 2 excludes substances subject to the Suchtmittelgesetz and lawfully marketed medicines from the NPSG; the dossier does not infer an SMG classification from the NPSV generic class. For a covered NPS, NPSG § 4(1) criminalizes for-profit manufacture, import, export, transfer or provision when intended for another person's or a third party's psychoactive use, with up to two years' imprisonment; § 4(2) provides one to ten years where the offence causes death or serious injury to a larger number of people. NPSG § 5 provides confiscation and says that, for StPO procedure, an NPS is treated as an object whose possession is generally prohibited, but that wording is not a basis to state that every personal possession circumstance is independently a § 4 offence. SMG § 27's narcotics penalties are reported only conditionally because the inspected SV did not establish that 2C-P is an SMG Suchtgift: unauthorized acquisition, possession, manufacture, transport, import/export, offer, transfer or provision of a Suchtgift carries up to one year or 360 daily rates, with up to six months or 360 daily rates for conduct exclusively for personal use; higher maxima apply to specified aggravated conduct. The exact-name SMG status and any case-specific medicine-law exception remain a bounded legal question.

The MHLW current designated-substances schedule lists 2C-P as a designated substance, not as a narcotic or psychotropic. The inspected current MHLW narcotics schedule and both statutory and decree psychotropics schedules contained no 2C-P or matching chemical-name entry. Under PMD Act Article 76-4, the listed substance and its salts may not be manufactured, imported, sold, transferred, possessed, purchased, received, or used for purposes other than the statutory medical等用途 (medical diagnosis, treatment or prevention, or other ministerially specified uses that do not risk harm to the human body). This is a general non-medical prohibition, not a prescription-only classification; the medical等用途 exception does not make ordinary recreational possession or use lawful. For a non-business violation, Article 84(28) provides up to three years' 拘禁刑 (拘禁刑; the current statutory custodial penalty) or a fine up to ¥3,000,000, or both. Business manufacture, import, sale, transfer, or possession for sale/transfer (storage or display for that purpose) is separately covered by Article 83-9 and carries up to five years' 拘禁刑 or a fine up to ¥5,000,000, or both. These are statutory maximums.

Repaired classification: 2C-P is not currently unscheduled or merely pending review. The current List IA generic 2-phenethylamine group covers its 2-phenylethan-1-amine core and its 2,5-dimethoxy-4-propyl phenyl substitution (alkoxy and alkyl substituents up to C6). Article 2a(1) prohibits import/export, preparation, processing, sale, delivery, supply, transport, possession and manufacture of covered substances or preparations. Article 2a(2) exceptions remain applicable; no claim is made that the prohibition overrides authorized medicines, veterinary products, registered precursors or other listed exceptions.

The legacy entry's substance is supported but its status label is normalized from "Illegal" to canonicalStatus prohibited and its instrument is made precise. The official Gazette decision expressly identifies 2C-P as item 1(b) under "Fenetilamin grubu maddelerden" and states that the annexed substances are made subject to Law No. 2313 pursuant to Article 19. The Turkish Narkotic Suçlarla Mücadele Başkanlığı's 2011 national report independently records that 2C-P was among the substances made subject to Law 2313 by the 13 February 2011 Gazette decision, and explains that the Article 19 process places a newly identified psychoactive substance under the law through a Health Ministry proposal and Council of Ministers decision. The latest general official report located, the 2025 Türkiye Uyuşturucu Raporu, describes Law No. 2313 as one of Turkey's core drug-control statutes, identifies TCK Article 188 as the manufacture/trade provision and Article 191 as the provision covering use or possession for use, and reports that 1,078 NPS had been brought within Law 2313 through 31 July 2025. The current Adalet Ministry TCK text provides the conduct-level controls: Article 188(1) covers unlicensed or unauthorized manufacture, import or export; Article 188(3) covers domestic sale, offering, giving, dispatch, transport, storage, purchase, acceptance or possession; and Article 191(1) covers buying, accepting, possessing or using for personal use. The TCK text gives the currently published penalty ranges, but this dossier does not assert a specific sentence for a particular 2C-P case. It also does not infer that the Article 188(4)(a) half-increase for amphetamine and derivatives applies to 2C-P merely because 2C-P is listed under the phenethylamine heading. The official schedule decision does not describe a medical, research, licensing or quantity exception; any authorization or exception must therefore be checked against the operative Turkish legislation for the particular conduct. A bounded currentness gap remains: the official sources inspected confirm the 2011 exact-name listing and the 2025 report confirms the continuing national NPS-control framework through 31 July 2025, but I did not locate a 2026 consolidated 2C-P schedule or an official amendment expressly confirming or repealing this individual entry. The 2026 Narkolog profile report is not a controlled-substances schedule and its absence of a 2C-P profile is not treated as evidence of legal status.